Data / Form D filings / Resilient Biotics, Inc.
Resilient Biotics, Inc.: Form D filings
Resilient Biotics, Inc., a biotechnology company in Research Triangle Park, NC, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on December 12, 2024, reports $3.9 million sold of a $4.6 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 DAVIS DRIVE, Research Triangle Park, NC, 27709
- Phone
- (717) 350-3133
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1836461
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Amendment | $4,600,000 | $3,862,000 | $738,000 | 6 | Aug 16, 2022 | sec.gov |
| Sep 6, 2024 | Amendment | $4,000,000 | $3,837,000 | $163,000 | 5 | Aug 16, 2022 | sec.gov |
| Aug 19, 2022 | New notice | $3,000,000 | $2,362,000 | $638,000 | 4 | Aug 16, 2022 | sec.gov |
| Dec 15, 2020 | New notice | $7,172,432 | $7,172,432 | 18 | Dec 2, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Eason | Director | |
| John Peryam | Director | |
| Rachelle Galvin | Executive Officer, Director | |
| Drew Lanza | Director | |
| Christopher Belnap | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Dec 9, 2024 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Resilient Biotics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.